All Stories

  1. Cigarette smoking affects microRNAs and inflammatory biomarkers in healthy individuals and an association to single nucleotide polymorphisms is indicated
  2. Single-Nucleotide Polymorphisms and Cancer Risk, Tumor Recurrence, or Survival of Head and Neck Cancer Patients
  3. Systematic review of Swedish snus for smoking cessation based on primary subject data from randomised clinical trials
  4. The in vitro toxicology of Swedish snus
  5. Thein vitrotoxicology of Swedish snus
  6. Tobacco Habits Interview
  7. Population-based survey of cessation aids used by Swedish smokers
  8. Swedish snus and the GothiaTek® standard
  9. Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation
  10. Cancer patients without a known primary: Incidence and survival trends in Sweden 1960-2007
  11. Olfactory changes among patients receiving chemotherapy
  12. Taste and Smell Changes in Patients Receiving Cancer Chemotherapy
  13. Taste and Smell Changes in Patients Receiving Cancer Chemotherapy
  14. Self-reported taste and smell changes during cancer chemotherapy
  15. Factors associated with return to work after breast cancer treatment
  16. Expression of COX-2 and steroid converting enzymes in breast cancer
  17. Waiting times for cancer patients – a “slippery slope” in oncology
  18. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among ‘high risk’ pre- and postmenopausal breast cancer patients
  19. Flawed methods
  20. Aromatase inhibitors in the treatment of early and advanced breast cancer
  21. Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
  22. Clinical effectiveness of radiotherapy for breast cancer: a summary
  23. Adjuvant endocrine therapy
  24. Side Effects of Adjuvant Endocrine Treatment in Premenopausal Breast Cancer Patients: A Prospective Randomized Study
  25. Akt kinases in breast cancer and the results of adjuvant therapy
  26. Amplification of HSD17B1 and ERBB2 in primary breast cancer
  27. A Systematic Overview of Radiation Therapy Effects in Breast Cancer
  28. Long-term effects of mammography screening: updated overview of the Swedish randomised trials
  29. Partial irradiation of the heart
  30. Surgical treatment for skeletal breast cancer metastases
  31. Trends in mortality from malignant melanoma in Sweden, 1970-1996
  32. Occupational and Residential Magnetic Field Exposure and Breast Cancer in Females
  33. Postmastectomy radiotherapy: randomized trials
  34. Randomised trial of long-term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone in patients with early-stage breast cancer treated with breast-conserving surgery
  35. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer
  36. Magnetic Fields and Breast Cancer in Swedish Adults Residing near High-Voltage Power Lines
  37. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery
  38. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast‐conserving surgery
  39. S25 Novel approaches using radiation techniques
  40. Controversial Issues in Adjuvant Systemic Therapy of Early Breast Cancer
  41. Outcomes of patients with local recurrence of cutaneous malignant melanoma
  42. Outcomes of patients with local recurrence of cutaneous malignant melanoma
  43. Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial
  44. Prostate carcinoma and long term survival
  45. Prostate carcinoma and long term survival
  46. Incidence of Primary Malignancies Other Than Breast Cancer among Women Treated with Radiation Therapy for Benign Breast Disease
  47. Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy
  48. Biology and Cost-benefit in Mammography Screening
  49. Adjuvant preoperative radiotherapy in patients with rectal carcinoma: Adverse effects during long term follow‐up of two randomized trials
  50. Adjuvant preoperative radiotherapy in patients with rectal carcinoma: Adverse effects during long term follow-up of two randomized trials
  51. The Swedish Randomised Mammography Screening Trials: Analysis of Their Effect on the Breast Cancer Related Excess Mortality
  52. Forum—Letter to the editor
  53. An Overview of the Swedish Randomised Mammography Trials: Total Mortality Pattern and the Representivity of the Study Cohorts
  54. Breast Cancer
  55. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma
  56. Determination of Cause of Death Among Breast Cancer Cases in the Swedish Randomized Mammography Screening Trials: A comparison between official statistics and validation by an endpoint committee
  57. Randomized adjuvant breast cancer trials in Sweden
  58. Prognostic factors in thin cutaneous malignant melanoma
  59. Morbidity of ischemic heart disease in early breast cancer 15–20 years after adjuvant radiotherapy
  60. Relationship of DNA Ploidy and S-Phase Fraction to Survival After First Recurrence of Breast Cancer
  61. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960–1984
  62. What Is the Value of Clinical Trials?
  63. What Have We Learned from the Stockholm Trials on Adjuvant Radiation Therapy in Early-Stage Breast Cancer?
  64. Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer
  65. Lack of correlation between anxiety parameters and oestrogen receptor status in early breast cancer
  66. Prognostic factors and natural history in lymph node-negative breast cancer patients
  67. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer
  68. Analysis of Hormone Receptors and Proliferation Fraction in Fine-Needle Aspirates from Primary Breast Carcinomas During Chemotherapy or Tamoxifen Treatment
  69. Randomized Trial of Adjuvant Tamoxifen in Node Negative Postmenopausal Breast Cancer
  70. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients
  71. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients
  72. Lymph-node irradiation in operable breast cancer and statistical power
  73. Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer
  74. Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials
  75. Cystosarcoma phyllodes of the breast: A cytologic and clinicopathologic study of 23 cases
  76. Adjuvant Therapy in Postmenopausal Patients with Operable Breast Cancer
  77. Temporal Trends in Breast Cancer Survival in Sweden: Significant Improvement in 20 Years2
  78. Reduced recurrence-free survival after reduced doses of adjuvant chemotherapy in breast cancer: Are groups selected after randomization comparable?
  79. Some aspects on validity of breast cancer, pancreatic cancer and lung cancer registration in Swedish official statistics
  80. Long-term survival of 458 young breast cancer patients
  81. Undernotification of Diagnosed Cancer Cases to the Stockholm Cancer Registry
  82. Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the cancer registry of Norway